Annual Shareholders Equity
$3.36 M
-$8.43 M-71.50%
December 31, 2023
Summary
- As of February 8, 2025, AMPE annual stockholders equity is $3.36 million, with the most recent change of -$8.43 million (-71.50%) on December 31, 2023.
- During the last 3 years, AMPE annual shareholders equity has fallen by -$14.15 million (-80.81%).
- AMPE annual shareholders equity is now -94.92% below its all-time high of $66.12 million, reached on December 31, 2014.
Performance
AMPE Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$3.36 M
-$2.02 M-37.49%
December 31, 2023
Summary
- As of February 8, 2025, AMPE quarterly stockholders equity is $3.36 million, with the most recent change of -$2.02 million (-37.49%) on December 31, 2023.
- Over the past year, AMPE quarterly shareholders equity has dropped by -$8.43 million (-71.50%).
- AMPE quarterly shareholders equity is now -96.15% below its all-time high of $87.33 million, reached on March 31, 2014.
Performance
AMPE Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
AMPE Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -71.5% | -71.5% |
| 3 y3 years | -80.8% | -80.8% |
| 5 y5 years | -35.8% | -35.8% |
AMPE Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -87.7% | at low | -87.7% | at low |
| 5 y | 5-year | -87.7% | at low | -87.7% | +68.6% |
| alltime | all time | -94.9% | +109.8% | -96.2% | +109.8% |
Ampio Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $3.36 M(-71.5%) | $3.36 M(-37.5%) |
| Sep 2023 | - | $5.38 M(-18.1%) |
| Jun 2023 | - | $6.56 M(-16.7%) |
| Mar 2023 | - | $7.88 M(-33.2%) |
| Dec 2022 | $11.79 M(-56.8%) | $11.79 M(-14.9%) |
| Sep 2022 | - | $13.85 M(-31.1%) |
| Jun 2022 | - | $20.10 M(-9.7%) |
| Mar 2022 | - | $22.25 M(-18.4%) |
| Dec 2021 | $27.28 M(+55.8%) | $27.28 M(+57.9%) |
| Sep 2021 | - | $17.27 M(-15.2%) |
| Jun 2021 | - | $20.36 M(+21.4%) |
| Mar 2021 | - | $16.78 M(-4.2%) |
| Dec 2020 | $17.51 M(+171.8%) | $17.51 M(+63.3%) |
| Sep 2020 | - | $10.72 M(+69.1%) |
| Jun 2020 | - | $6.34 M(+218.3%) |
| Mar 2020 | - | $1.99 M(-69.1%) |
| Dec 2019 | $6.44 M(+23.1%) | $6.44 M(+55.7%) |
| Sep 2019 | - | $4.14 M(-62.8%) |
| Jun 2019 | - | $11.11 M(-2474.0%) |
| Mar 2019 | - | -$468.00 K(-108.9%) |
| Dec 2018 | $5.24 M(-115.3%) | $5.24 M(+134.1%) |
| Sep 2018 | - | $2.24 M(-159.4%) |
| Jun 2018 | - | -$3.77 M(-57.4%) |
| Mar 2018 | - | -$8.86 M(-74.1%) |
| Dec 2017 | -$34.18 M(-615.2%) | -$34.18 M(>+9900.0%) |
| Sep 2017 | - | -$199.50 K(-105.3%) |
| Jun 2017 | - | $3.73 M(-25.6%) |
| Mar 2017 | - | $5.02 M(-24.3%) |
| Dec 2016 | $6.63 M(-82.1%) | $6.63 M(-32.1%) |
| Sep 2016 | - | $9.77 M(-25.6%) |
| Jun 2016 | - | $13.14 M(-26.7%) |
| Mar 2016 | - | $17.92 M(-51.6%) |
| Dec 2015 | $37.00 M | $37.00 M(-17.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2015 | - | $44.92 M(-12.5%) |
| Jun 2015 | - | $51.35 M(-14.8%) |
| Mar 2015 | - | $60.28 M(-8.8%) |
| Dec 2014 | $66.12 M(+99.9%) | $66.12 M(-9.8%) |
| Sep 2014 | - | $73.30 M(-8.7%) |
| Jun 2014 | - | $80.24 M(-8.1%) |
| Mar 2014 | - | $87.33 M(+164.0%) |
| Dec 2013 | $33.08 M(+38.8%) | $33.08 M(-13.0%) |
| Sep 2013 | - | $38.03 M(+108.5%) |
| Jun 2013 | - | $18.24 M(-20.7%) |
| Mar 2013 | - | $22.99 M(-3.5%) |
| Dec 2012 | $23.83 M(+34.2%) | $23.83 M(-10.9%) |
| Sep 2012 | - | $26.75 M(+95.9%) |
| Jun 2012 | - | $13.65 M(-10.2%) |
| Mar 2012 | - | $15.20 M(-14.4%) |
| Dec 2011 | $17.76 M(-543.1%) | $17.76 M(+35.9%) |
| Sep 2011 | - | $13.07 M(-8.3%) |
| Jun 2011 | - | $14.26 M(+33.6%) |
| Mar 2011 | - | $10.67 M(-366.2%) |
| Dec 2010 | -$4.01 M(+1395.7%) | -$4.01 M(+160.4%) |
| Sep 2010 | - | -$1.54 M(+131.1%) |
| Jun 2010 | - | -$666.00 K(-1678.2%) |
| Mar 2010 | - | $42.20 K(-115.7%) |
| Dec 2009 | -$268.00 K(+510.5%) | -$268.00 K(+317.4%) |
| Sep 2009 | - | -$64.20 K(+8.4%) |
| Jun 2009 | - | -$59.20 K(+8.6%) |
| Mar 2009 | - | -$54.50 K(+24.1%) |
| Dec 2008 | -$43.90 K(+265.8%) | -$43.90 K(+13.1%) |
| Sep 2008 | - | -$38.80 K(+22.4%) |
| Jun 2008 | - | -$31.70 K(+11.6%) |
| Mar 2008 | - | -$28.40 K(+136.7%) |
| Dec 2007 | -$12.00 K(-160.0%) | -$12.00 K(+275.0%) |
| Sep 2007 | - | -$3200.00(-116.0%) |
| Dec 2006 | $20.00 K | $20.00 K |
FAQ
- What is Ampio Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals annual shareholders equity year-on-year change?
- What is Ampio Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Ampio Pharmaceuticals?
- What is Ampio Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Ampio Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of AMPE is $3.36 M
What is the all time high annual shareholders equity for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high annual stockholders equity is $66.12 M
What is Ampio Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, AMPE annual stockholders equity has changed by -$8.43 M (-71.50%)
What is Ampio Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of AMPE is $3.36 M
What is the all time high quarterly shareholders equity for Ampio Pharmaceuticals?
Ampio Pharmaceuticals all-time high quarterly stockholders equity is $87.33 M
What is Ampio Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, AMPE quarterly stockholders equity has changed by -$8.43 M (-71.50%)